AEON Biopharma, Inc. is an innovative biopharmaceutical company based in Newport Beach, California, specializing in the development of botulinum toxin products aimed at addressing a range of debilitating medical conditions. The company's robust pipeline emphasizes the therapeutic potential of its proprietary formulations, positioning AEON as a key player in the neuromodulators market. With a commitment to advancing treatment options and improving patient outcomes, AEON is strategically positioned to capitalize on the growing demand for effective interventions in both aesthetic and therapeutic applications.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

5 PARK PLAZA, IRVINE, CA, UNITED STATES, 92614

December

$9.43 Million

-$17.9 Million

0.0

-13.91

$0.00

0.0%

0.743